Study Title: Randomized Phase III Trial of Neoadjuvant Immunotherapy with Response-Adapted Treatment Versus Standard-of-Care Treatment for Resectable Stage III/IV Cutaneous Squamous Cell Carcinoma
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Albergotti, William, at albergot@musc.edu.Study Coordinator, Avinger, Madison, at avingerm@musc.edu.Trial opened at the following institutions: Medical University of South Carolina